Flovent Aerosol, Metered
Product Images NDC 50090-0934

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Flovent (NDC 50090-0934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Floventhfa Spl Graphic 01)

FDA Label Image

Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Floventhfa Spl Graphic 02)

FDA Label Image

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Floventhfa Spl Graphic 03)

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Floventhfa Spl Graphic 03)
The text describes the percentage change in FEV (Forced Expiratory Volume) from baseline for different dosages of FLOVENT HFA and placebo in a study. The dosages tested were 88mcg, 220mcg, and 440mcg twice daily. The results are shown in a graph with the baseline measures taken at day 1 and the endpoint measures taken at days 7 to 12.*
FDA Label Image

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Floventhfa Spl Graphic 04)

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Floventhfa Spl Graphic 04)
The text is describing a graph or chart that displays the percentage of subjects with an increase in dose and reduction in dose for two types of medication, "Placebo" and "FLOVENT HFA". The data is presented in percentages, with values ranging from 100% to as low as 3%. The text includes some symbols, such as "%" and "-", as well as some unclear characters.*
FDA Label Image

Figure A (Floventhfa Spl Graphic 05)

Figure A (Floventhfa Spl Graphic 05)
This appears to be a description of a metal canister with a dark orange plastic actuator and mouthpiece. It also has a counter peach cap.*
FDA Label Image

Figure B (Floventhfa Spl Graphic 06)

FDA Label Image

Fgure C (Floventhfa Spl Graphic 07)

FDA Label Image

Figure D (Floventhfa Spl Graphic 08)

FDA Label Image

Figure E (Floventhfa Spl Graphic 09)

Figure E (Floventhfa Spl Graphic 09)
The text is describing the position of a mouthpiece in a dark orange color, which appears to be in a "Mouthpiece-Down" position. It might be related to a musical instrument or some other device that requires a mouthpiece.*
FDA Label Image

Figure F (Floventhfa Spl Graphic 10)

Figure F (Floventhfa Spl Graphic 10)
This is a simple instruction on how to exhale as much air as possible.*
FDA Label Image

Figure G (Floventhfa Spl Graphic 11)

FDA Label Image

Figure H (Floventhfa Spl Graphic 12)

FDA Label Image

Figure I (Floventhfa Spl Graphic 13)

FDA Label Image

Floventhfa Spl Graphic 14

FDA Label Image

Label Image (Lbl500900934)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.